Evidence map›Paper›PMID 25266657›Full record

ArticleMolecular and cellular biology2014

ALK5 and ALK1 play antagonistic roles in transforming growth factor β-induced podosome formation in aortic endothelial cells.

Filipa Curado, Pirjo Spuul, Isabel Egaña, Patricia Rottiers, Thomas Daubon, Véronique Veillat, Paul Duhamel, Anne Leclercq, Etienne Gontier, Elisabeth Génot

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. Article
  8. Review
  9. Article
  10. Reevaluation of Pluripotent Cytokine TGF-β3 in Immunity.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Article
  13. Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Filipa CuradoIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Pirjo SpuulIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Isabel EgañaIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Patricia RottiersIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Thomas DaubonIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Véronique VeillatIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Paul DuhamelIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Anne LeclercqIECB and INSERM U1045, University of Bordeaux, Bordeaux, France.
Etienne GontierBordeaux Imaging Center, UMS 3420 CNRS/US4 INSERM, University of Bordeaux, Bordeaux, France.
Elisabeth GénotIECB and INSERM U1045, University of Bordeaux, Bordeaux, France e.genot@iecb.u-bordeaux.fr.
Université de Bordeaux · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transforming growth factor β (TGF-β) and related cytokines play a central role in the vascular system. In vitro, TGF-β induces aortic endothelial cells to assemble subcellular actin-rich structures specialized for matrix degradation called podosomes. To explore further this TGF-β-specific response and determine in which context podosomes form, ALK5 and ALK1 TGF-β receptor signaling pathways were investigated in bovine aortic endothelial cells. We report that TGF-β drives podosome formation through ALK5 and the downstream effectors Smad2 and Smad3. Concurrent TGF-β-induced ALK1 signaling mitigates ALK5 responses through Smad1. ALK1 signaling induced by BMP9 also antagonizes TGF-β-induced podosome formation, but this occurs through both Smad1 and Smad5. Whereas ALK1 neutralization brings ALK5 signals to full potency for TGF-β-induced podosome formation, ALK1 depletion leads to cell disturbances not compatible with podosome assembly. Thus, ALK1 possesses passive and active modalities. Altogether, our results reveal specific features of ALK1 and ALK5 signaling with potential clinical implications.

Indexed as

Actin CytoskeletonActivin ReceptorsAnimalsAortaCattleEndothelial CellsGrowth Differentiation Factor 2MiceMice, Inbred C57BLMice, TransgenicProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISignal TransductionSmad Proteins, Receptor-RegulatedTransforming Growth Factor betaActivin ReceptorsGrowth Differentiation Factor 2Protein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISmad Proteins, Receptor-RegulatedTgfbr1 protein, mouseTransforming Growth Factor beta

Identifiers

PMID25266657
PMCPMC4248735
OpenAlexW2101764771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.